HELSINKI, 6. März 2023 /PRNewswire/ — Sooma Medical, ein in Finnland ansässiges Medizintechnikunternehmen, hat von der US-amerikanischen Food and Drug Administration (FDA) den Status eines bahnbrechenden Produkts für sein tragbares, vom Patienten zu verabreichendes Neuromodulationsgerät…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.